Thuraiaiyah, Janu
Ashina, Håkan
Christensen, Rune Häckert
Al-Khazali, Haidar M.
Ashina, Messoud
Funding for this research was provided by:
Lundbeck Foundation (R310-2018-3711)
Copenhagen University
Article History
Received: 21 October 2023
Accepted: 14 January 2024
First Online: 21 February 2024
Declarations
:
: The study protocol for the parental studied received approval from the ethics committee of the Capital Region of Denmark and the Danish Data Protection Agency (H‐20033264 and H‐20047793). Furthermore, the study was conducted in adherence with the principles outlined in Helsinki Declaration, 7th revision. All participants provided written informed consent before any study-related tasks or procedures were performed.
: Not applicable.
: JT and RHC declare that they have no competing interests. HA reports personal fees from Lundbeck and Teva, outside of the submitted work. HMA reports personal fees from Pfizer, outside of the submitted work. MA reports receiving personal fees from AbbVie, Amgen, Eli Lilly, Lundbeck, Novartis, Pfizer and Teva Pharmaceuticals outside of the submitted work. MA received institutional grants from Lundbeck Foundation, Novo Nordisk Foundation, and Novartis. MA reports serving as associate editor of Cephalalgia, associate editor of The Journal of Headache and Pain, and associate editor of Brain.